Immune checkpoint inhibitors for ocular melanoma
Not Applicable
- Conditions
- Ocular melanoma
- Registration Number
- JPRN-UMIN000047431
- Lead Sponsor
- Yokohama City University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with ocular melanoma who were treated with ICI as adjuvant/neoadjuvant therapy
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ORR, DCR, PFS, and OS among patients with ocular melanoma who were treated with ICI.
- Secondary Outcome Measures
Name Time Method